Results 161 to 170 of about 47,200 (309)

Dabigatran after cardiac surgery: Caution advised [PDF]

, 2011
Alexander Kulik, Mark B. Saltzman, James J. Morris   +2 more
openalex   +1 more source

Dabigatran Etexilate [PDF]

, 2011
Graeme J. Hankey, John W. Eikelboom
openalex   +1 more source

JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias

Journal of Arrhythmia, Volume 41, Issue 3, June 2025.
Yu‐ki Iwasaki, Takashi Noda, Masaharu Akao, Tadashi Fujino, Teruyuki Hirano, Koichi Inoue, Kengo Kusano, Toshiyuki Nagai, Kazuhiro Satomi, Tetsuji Shinohara, Kyoko Soejima, Yohei Sotomi, Shinya Suzuki, Teiichi Yamane, Tsukasa Kamakura, Hiroyuki Kato, Arimi Katsume, Yusuke Kondo, Kenji Kuroki, Hisaki Makimoto, Hiroshige Murata, Takafumi Oka, Nobuaki Tanaka, Nobuhiko Ueda, Hiro Yamasaki, Seigo Yamashita, Ryobun Yasuoka, Kenji Yodogawa, Kazutaka Aonuma, Takanori Ikeda, Toru Minamino, Hideo Mitamura, Akihiko Nogami, Ken Okumura, Hiroshi Tada, Takashi Kurita, Wataru Shimizu, on behalf of the Japanese Circulation Society and Japanese Heart Rhythm Society Joint Working Group   +37 more
wiley   +1 more source

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial: reply to a rebuttal [PDF]

, 2011
Karl‐Heinz Liesenfeld, Thorsten Lehr, C. Dansirikul, Paul Reilly, Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, Lars Wallentin, Sebastian Haertter, Alexander Staab   +9 more
openalex   +1 more source

Dabigatran Is Not a Direct Xa Inhibitor

Journal of the American College of Cardiology, 2012
Basra et al. ([1][1]) wrote a timely state-of-the-art paper on “safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease” in the Journal .
openaire   +3 more sources

Anticoagulant Options — Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran [PDF]

, 2011
B. Nhi Beasley, Ellis F. Unger, Robert Temple   +2 more
openalex   +1 more source

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

New England Journal of Medicine, 2017
C. Cannon, Deepak L. Bhatt, J. Oldgren, G. Lip, S. Ellis, Takeshi Kimura, M. Maeng, B. Merkely, U. Zeymer, S. Gropper, M. Nordaby, E. Kleine, Ruth Harper, Jenny Manassie, J. Januzzi, J. T. ten Berg, G. Steg, S. Hohnloser   +17 more
semanticscholar   +1 more source

Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report

International Journal of Emergency Medicine
Dabigatran is an oral anticoagulant that is mainly renally excreted. Despite its efficacy in preventing thromboembolic events, concerns arise regarding bleeding complications in patients with acute kidney injury. Idarucizumab is its specific antidote and
Rafik Matbouli, Olivier Pantet, Julien Castioni, Nima Vakilzadeh, Lorenzo Alberio, Olivier Hugli   +5 more
doaj   +1 more source

Place of Dabigatran in Contemporary Pharmacotherapy [PDF]

, 2011
John G. Gums
openalex   +1 more source

Lack of an antagonist to reverse the action of dabigatran [PDF]

, 2011
Oscar M.P. Jolobe
openalex   +1 more source